KCNQ1 rs163184: Understanding This Type 2 Diabetes Associated Variant
The rs163184 variant is a single nucleotide polymorphism located within the KCNQ1 gene. It has been identified in research as a susceptibility marker associated with insulin sensitivity, beta-cell response, and type 2 diabetes risk.
What each genotype means
Typical insulin response profile
This genotype represents the more common version of this variant in many populations. Research suggests that individuals with this profile may have a standard baseline for insulin sensitivity and beta-cell function, though these associations are complex and influenced by diet. Because the evidence linking this variant to metabolic traits is limited, this result should not be used to predict specific health outcomes.
Carried by approximately 40-45% of individuals of European ancestry, based on typical allele frequencies.
Intermediate metabolic association
Carrying one copy of the T allele may be associated with subtle differences in how your body manages insulin and beta-cell response. Studies indicate that the impact of this variant can be modified by lifestyle factors, such as carbohydrate intake and adherence to a Mediterranean diet. This association is considered limited in strength, and you should focus on overall healthy lifestyle habits rather than this specific genetic marker.
Carried by roughly 45-50% of individuals of European ancestry.
Potential metabolic sensitivity
This genotype is associated with variations in insulin sensitivity and beta-cell response in some research studies. The clinical significance of this finding is limited, and the observed effects are often dependent on dietary patterns and other environmental factors. Please discuss your metabolic health and any concerns about blood sugar management with your primary care physician.
Carried by approximately 10-15% of individuals of European ancestry, with higher frequencies observed in some East Asian populations.
What is rs163184 and Where is it Located?
The variant rs163184 is a single nucleotide polymorphism (SNP) situated in the intronic region of the KCNQ1 gene on chromosome 11. In genetics, an intronic region refers to a non-coding sequence within a gene that is removed during the process of creating a functional protein. Despite being non-coding, intronic variants can play critical roles in gene regulation. Research indicates that the genomic region containing rs163184 co-localizes with markers of active regulatory elements in tissues such as human skeletal muscle, adipose tissue, and pancreatic islets. This suggests that while the variant does not change the protein structure of KCNQ1 itself, it may influence how the gene is expressed or how it interacts with other regulatory proteins, such as Sp3 and Lsd1/Kdm1a, which are involved in modulating gene activity.
The Role of the KCNQ1 Gene
The KCNQ1 gene is widely recognized for encoding the pore-forming subunit of a voltage-gated potassium channel. These channels are essential for the repolarization phase of action potentials, particularly in cardiac muscle, where they help regulate the heart's electrical rhythm. Beyond the heart, KCNQ1 is expressed in the pancreas, where it plays a significant role in the function of beta-cells. Beta-cells are responsible for producing and secreting insulin in response to blood glucose levels. Because of this function, variations in or near the KCNQ1 gene have been extensively studied for their potential impact on insulin secretion and glucose homeostasis. Understanding how this gene influences pancreatic function is a major focus of research into the genetic architecture of metabolic conditions like type 2 diabetes.
Research Associations and Evidence Strength
The association between rs163184 and type 2 diabetes has been highlighted in various genome-wide association studies (GWAS). Research suggests that this variant may modulate the binding activity of regulatory proteins, potentially affecting the expression of nearby genes like CDKN1C. While the evidence linking rs163184 to type 2 diabetes susceptibility is statistically significant in large-scale studies, the functional impact remains a subject of ongoing investigation. It is important to note that the evidence strength for this specific variant is considered limited in terms of clinical utility. Genetic associations are complex, and the presence of a risk allele does not guarantee the development of a condition. Many factors, including diet, physical activity, and other genetic markers, contribute to metabolic health. Consequently, this variant should be viewed as one piece of a much larger, multifactorial puzzle rather than a definitive diagnostic tool.
What You Can and Cannot Do With This Information
Information about genetic variants like rs163184 is primarily educational and intended to provide insight into the biological factors that may influence metabolic traits. You cannot use this information to diagnose yourself with a medical condition or to predict your future health outcomes with certainty. Genetic data is not a substitute for professional medical advice, screening, or diagnostic testing. If you are concerned about your risk for type 2 diabetes or your metabolic health, the most effective steps involve consulting with a healthcare provider to discuss your family history, lifestyle, and clinical markers like blood glucose levels. Never make changes to your diet, exercise, or medication regimen based solely on genetic test results without first speaking with a qualified clinician or registered dietitian who can provide personalized guidance based on your overall health profile.
How common is this variant?
The rs163184 variant is relatively common, with a minor allele frequency of approximately 0.35 in populations of European ancestry and approximately 0.45 in populations of East Asian ancestry.
Frequently asked questions
Is rs163184 a diagnostic test for diabetes?
No, rs163184 is not a diagnostic test. It is a genetic marker associated with susceptibility in research studies, but it does not determine whether an individual will develop diabetes.
Does this variant mean I should change my diet?
Genetic variants do not provide specific dietary prescriptions. You should discuss any significant changes to your diet with a healthcare professional or a registered dietitian who can evaluate your overall health needs.
Where can I find more information on KCNQ1?
You can find reliable information on the KCNQ1 gene through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Are there other genes involved in diabetes risk?
Yes, type 2 diabetes is a complex, polygenic condition. Hundreds of genetic variants across many different genes are known to contribute to an individual's overall risk profile.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs163184?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KCNQ1
A rare variant in the KCNQ1 gene associated with Long QT syndrome.
Pathogenic missense variant associated with Long QT syndrome type 1.
This variant is associated with Long QT syndrome 1, a condition affecting the heart's electrical activity.
Pathogenic variant associated with Long QT Syndrome type 1 (Romano-Ward syndrome).
Intronic variant in KCNQ1 associated with type 2 diabetes susceptibility and fasting glucose levels.
Truncating variant p.Arg518Ter in KCNQ1 associated with Long QT Syndrome type 1.